EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta‐analysis

Renate Dagsdottir Laumann iD, Louise Lindkvist Pedersen, Liv Andrés-Jensen, Christian Mølgaard, Kjeld Schmiegelow iD, Thomas Leth Frandsen iD, Bodil Als-Nielsen

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30683 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Renate Dagsdottir Laumann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hyperlipidemias. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Danish Childhood Cancer Foundation, Dagmar Marshall's Foundation, Knud and Edith Eriksens Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The established association between acute lymphoblastic leukemia (ALL) and hyperlipidemia has, in some studies, been linked to toxicities such as pancreatitis, thrombosis, and osteonecrosis. However, a systematic review investigating the incidence, management, and clinical implications of hyperlipidemia during childhood ALL treatment is lacking.

Objectives

Systematically assess the incidence of hyperlipidemia during ALL treatment, explore associations with risk factors and severe toxicities (osteonecrosis, thrombosis, and pancreatitis), and review prevalent management strategies.

Methods

A systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement. Data synthesis was descriptive, and a meta‐analysis of hypertriglyceridemia and risk of severe toxicities was performed.

Results

We included 13 studies with 3,425 patients. Hyperlipidemia incidence varied widely (6.7%‐85%) but with inconsistent definitions and screening strategies across studies. Evidence regarding risk factors was conflicting, but age (> 10 years) and treatment with asparaginase and glucocorticosteroids seem to be associated with hyperlipidemia. Hypertriglyceridemia (grade 3/4) increased the risk for osteonecrosis (odds ratio (OR): 4.27, 95% confidence interval (CI): 2.77‐6.61). No association could be established for pancreatitis (OR: 1.60, 95% CI: 0.53‐4.82) or thrombosis (OR: 2.45, 95% CI: 0.86‐7.01), but larger studies are needed to confirm this.

Conclusion

The overall evidence of this systematic review is limited by the small number of studies and risk of bias. Our review suggests that hypertriglyceridemia increases the risk for osteonecrosis. However, larger studies are needed to explore the clinical implications of hyperlipidemia and randomized trials investigating hyperlipidemia management and its impact on severe toxicities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaHyperlipidemiasHumansChildAdolescentRisk FactorsOsteonecrosisIncidenceChild, Preschool

Stichwörter der Autor:innen

Acute lymphoblastic leukemiahyperlipidemiapediatricstoxicities

Autor:innen und Institutionen

  • Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
  • Pediatric Nutrition Unit, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Renate Dagsdottir Laumann, Kjeld Schmiegelow, Thomas Leth Frandsen

Förderung

  • Danish Childhood Cancer Foundation
  • Dagmar Marshall's Foundation
  • Knud and Edith Eriksens Foundation
  • Danish Cancer Society
  • Børnecancerfonden
  • Kræftens Bekæmpelse

Zitieren

APA

Laumann, R. D., Pedersen, L. L., Andrés-Jensen, L., Mølgaard, C., Schmiegelow, K., Frandsen, T. L., & Als-Nielsen, B. (2023). Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta‐analysis. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30683

Vancouver

Laumann RD, Pedersen LL, Andrés-Jensen L, Mølgaard C, Schmiegelow K, Frandsen TL, et al. Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta‐analysis. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30683

BibTeX
@article{Laumann2023,
  author = {Laumann, Renate Dagsdottir and Pedersen, Louise Lindkvist and Andrés-Jensen, Liv and Mølgaard, Christian and Schmiegelow, Kjeld and Frandsen, Thomas Leth and Als-Nielsen, Bodil},
  title = {Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta‐analysis},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30683}
}
Kostenlos starten →